On October 31, 2025, the Centers for Medicare & Medicaid Services (“CMS”) issued the Calendar Year 2026 Medicare Physician Fee Schedule...
Reed Smith LLP
In the first week of September, the U.S. Department of Health and Human Services (HHS) announced a renewed enforcement focus on...
The U.S. Department of Health and Human Services (“HHS”), along with several other agencies (the Departments of Labor and Treasury, as...
Recent guidance from the Centers for Medicare & Medicaid Services (CMS), along with the passage of the 2025 Reconciliation Law...
The U.S. Department of Health and Human Services (HHS) has announced a new general policy on what factors the agency will take into...
The U.S. Department of Health and Human Services (HHS) is still looking for stakeholders to comment on what regulations should be...
Late on Wednesday June 18, Judge Matthew J. Kacsmaryk of the U.S. District Court for the Northern District of Texas issued an order...
On June 9, 2025, Oregon updated its Corporate Practice of Medicine (“CPOM”) doctrine by passing SB 951, to, among other things, prohibit...
In February 1971, at the tail end of Richard Nixon’s first term, his Secretary of Health, Education and Welfare, Elliot Richardson,...
In a significant ruling among the first to analyze the application of information blocking regulations, the U.S. Court of Appeals for the...
Reed Smith has announced the dates and topics for it’s 11th annual health care conference from March 17-21, 2024. The conference will be...
On January 17, 2025, the Drug Enforcement Administration (DEA) announced a proposed rule to establish a special registration framework...
In its first advisory opinion of the year, the Department of Health and Human Services Office of Inspector General (OIG) issued a...
Hospitals and large healthcare organizations have increasingly become prime targets for cybercriminals. In response, the Department of...
Last week, on April 18, several federal agencies jointly launched a “one-stop shop” to facilitate reporting of allegedly anticompetitive...
The United States Food and Drug Administration (FDA) has proposed a rule on “Drug Products or Categories of Drug Products that Present...